Incidence of bloodstream infections in patients with covid-19: a retrospective cohort study of risk factors and outcomes

HIGHLIGHTS

• who: Posted Date August and collaborators from the Laboratory findings on admission, No(%) have published the article: Incidence of Bloodstream Infections in Patients with COVID-19: A Retrospective Cohort Study of Risk Factors and Outcomes, in the Journal: (JOURNAL)
• what: The authors did not have information on immunomodulatory therapies such as tocilizumab, which has been associated with increased risk of BSIs in critically ill patients with COVID-19.[29] the study has several strengths.
• how: For multivariable analysis the authors used logistic regression to identify independent predictors of BSIs during the hospital stay . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.